Inosine triphosphate pyrophosphatase from Trypanosoma brucei cleanses cytosolic pools from deaminated nucleotides.

Sci Rep

Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, Parque Tecnológico de Ciencias de la Salud, Avenida del Conocimiento, 17, 18016, Armilla, Granada, Spain.

Published: April 2022

Inosine triphosphate pyrophosphatases (ITPases) are ubiquitous house-cleaning enzymes that specifically recognize deaminated purine nucleotides and catalyze their hydrolytic cleavage. In this work, we have characterized the Trypanosoma brucei ITPase ortholog (TbITPA). Recombinant TbITPA efficiently hydrolyzes (deoxy)ITP and XTP nucleotides into their respective monophosphate form. Immunolocalization analysis performed in bloodstream forms suggests that the primary role of TbITPA is the exclusion of deaminated purines from the cytosolic nucleoside triphosphate pools. Even though ITPA-knockout bloodstream parasites are viable, they are more sensitive to inhibition of IMP dehydrogenase with mycophenolic acid, likely due to an expansion of IMP, the ITP precursor. On the other hand, TbITPA can also hydrolyze the activated form of the antiviral ribavirin although in this case, the absence of ITPase activity in the cell confers protection against this nucleoside analog. This unexpected phenotype is dependant on purine availability and can be explained by the fact that ribavirin monophosphate, the reaction product generated by TbITPA, is a potent inhibitor of trypanosomal IMP dehydrogenase and GMP reductase. In summary, the present study constitutes the first report on a protozoan inosine triphosphate pyrophosphatase involved in the removal of harmful deaminated nucleotides from the cytosolic pool.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9016069PMC
http://dx.doi.org/10.1038/s41598-022-10149-4DOI Listing

Publication Analysis

Top Keywords

inosine triphosphate
12
triphosphate pyrophosphatase
8
trypanosoma brucei
8
deaminated nucleotides
8
imp dehydrogenase
8
tbitpa
5
pyrophosphatase trypanosoma
4
brucei cleanses
4
cleanses cytosolic
4
cytosolic pools
4

Similar Publications

Article Synopsis
  • The study explored the effects of prickly ash seeds (PASs) in the diets of lambs, focusing on their potential to enhance meat quality and antioxidant activity.
  • Results showed that using 6% PASs significantly reduced cooking loss, increased fat content, and improved various meat quality metrics compared to a control group.
  • Additionally, PAS supplementation influenced the lambs' metabolism, enhancing their serum and muscle antioxidant capacity while potentially lowering overall feed costs.
View Article and Find Full Text PDF
Article Synopsis
  • Thiopurine drugs are used to treat conditions like inflammatory bowel disease, and their metabolism is influenced by the enzymes TPMT and ITPA.
  • This study focuses on Tunisian patients to assess how genetic factors and other variables affect the pharmacokinetics of thiopurine drugs.
  • The research found specific genetic variants and identified gender as a significant factor affecting drug variability, emphasizing the importance of TPMT testing for optimal treatment safety and efficacy.
View Article and Find Full Text PDF

De novo GTP synthesis is a metabolic vulnerability for the interception of brain metastases.

Cell Rep Med

October 2024

Centre for Discovery in Cancer Research, McMaster University, Hamilton, ON, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, Canada; Department of Surgery, McMaster University, Hamilton, ON, Canada. Electronic address:

Patients with brain metastases (BM) face a 90% mortality rate within one year of diagnosis and the current standard of care is palliative. Targeting BM-initiating cells (BMICs) is a feasible strategy to treat BM, but druggable targets are limited. Here, we apply Connectivity Map analysis to lung-, breast-, and melanoma-pre-metastatic BMIC gene expression signatures and identify inosine monophosphate dehydrogenase (IMPDH), the rate-limiting enzyme in the de novo GTP synthesis pathway, as a target for BM.

View Article and Find Full Text PDF

Purines and purinergic receptors in primary tumors of the central nervous system.

Purinergic Signal

October 2024

Department of Graduate Studies in Biomedical Sciences, Federal University of Fronteira Sul, Rodovia SC 484 - Km 02, Fronteira Sul, Chapecó, SC, CEP 89815-899, Brazil.

Article Synopsis
  • Purine nucleotides and nucleosides are crucial in various diseases, especially in tumor growth, with ATP promoting tumor receptor activation and adenosine acting as an immunosuppressant.
  • This study explores how ATP and its metabolites, along with specific receptors, impact primary central nervous system tumors and their progression.
  • The results suggest that the purinergic system's role in tumors can vary, acting as either a promoter or inhibitor of tumor growth, depending on receptor density and the surrounding environment, highlighting ATP's significance in cancer development.*
View Article and Find Full Text PDF

In cold human blood, the anomalous dynamics of adenosine triphosphate (ATP) result in the progressive accumulation of adenosine diphosphate (ADP), adenosine monophosphate (AMP), inosine monophosphate (IMP), inosine, and hypoxanthine. While the ATP, ADP, AMP, and IMP are confined to red blood cells (RBCs), inosine and hypoxanthine are excreted into plasma/serum. The plasma/serum levels of inosine and hypoxanthine depend on the temperature of blood and the plasma/serum contact time with the RBCs, and hence they represent robust biomarkers for evaluating the preanalytical quality of plasma/serum.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!